Obtain the Future Market Analysis for Separation Systems for Commercial Biotechnology at: http://bit.ly/2ixciSQ
The global separation systems commercial biotechnology market was valued at US$ 10,665.5 Mn in 2014. The wide area of application of the Separation systems in Biotechnology and Biopharmaceutical Industry will lead the market to rise at a 6.8% CAGR from 2015 to 2023.
Some of the factors that are driving the global separation systems commercial biotechnology market are: Technological advancements, Investment in R&D and increase in number of biotechnology firms.
The market overview section of the report includes qualitative analysis of the overall separation systems commercial biotechnology market including the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter’s Five Forces Analysis. In addition, various analyses such as market attractiveness analysis by geography and competitive landscape by key players have also been provided. The market attractiveness analysis explains the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis. These factors would help the market players to take strategic decisions in order to strengthen their positions and increase their shares in the global market.
The global separation systems commercial biotechnology market has been segmented based on product type, end-user, and geography. Based on product type, the separation systems market has been categorized into two major segments: liquid chromatography, membrane filters, electrophoresis instruments, flow cytometer instruments, centrifugation systems, DNA microarray instruments, protein microarray instruments, MACS & FACS systems, others (biochips, lab-on-a-chip, etc.). Based on application, the separation systems market has been segmented into five applications: life sciences research and diagnostics, pharmaceuticals, food & cosmetics, energy, and agriculture. Market revenue in terms of US$ Mn for the period between 2013 and 2023 along with the compound annual growth rate (CAGR %) from 2015 to 2023 is provided for all the segments, considering 2014 as the base year.
Read the Current Market Trends of Separation Systems for Commercial Biotechnology at: http://www.transparencymarketresearch.com/separation-systems-commercial-biotechnology-market.html
Geographically, the separation systems market commercial biotechnology has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe includes Germany, the U.K., and Rest of Europe. Asia Pacific comprises China, Japan, and Rest of Asia Pacific. Rest of the World comprises of Latin America, Middle East & Africa. The recommendations section included in the report would assist existing players to increase their market shares and new companies to establish their presence in the separation systems market. The report also profiles major players in the market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Danaher Corporation, Thermo Fisher Scientific, Inc., Waters Corporation, Becton, Dickinson and Company, GE Healthcare and Merck KGaA.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
No comments:
Post a Comment